Drug Type Small molecule drug |
Synonyms MC 5 - Valeant, MC5- RA - Valeant, JNJ 10229570 AAA + [4] |
Target |
Action antagonists |
Mechanism MC1R antagonists(Melanocortin receptor 1 antagonists), MC5R antagonists(Melanocortin receptor 5 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H19N3O2S |
InChIKeyXTHRTBCPBWJYRO-UHFFFAOYSA-N |
CAS Registry524923-88-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acne Vulgaris | Phase 2 | United States | 31 Mar 2011 | |
Pruritus | Phase 1 | Japan | 01 Aug 2011 |
Phase 2 | 431 | Vehicle Control (0% Facial Cream) | mwktdzvmul(jdemdinnym) = bmmpojsumv tjkhwhgnsg (fmfrvuflsx, 27.43) View more | - | 11 Dec 2018 | ||
(1.2% Facial Cream) | mwktdzvmul(jdemdinnym) = mehwqbyzix tjkhwhgnsg (fmfrvuflsx, 30.23) View more |